Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference86 articles.
1. Dameshek W. Editorial: some speculations on the myeloproliferative syndromes. Blood [Internet]. 19516(4):372–375. https://ashpublications.org/blood/article/6/4/372/42488/Editorial-Some-Speculations-on-the [cited 2023 Feb 15];
2. Martin K. Risk factors for and management of MPN-associated bleeding and thrombosis. Curr Hematol Malig Rep [Internet]. 2017 12(5):389–396. https://pubmed.ncbi.nlm.nih.gov/28948496/ [cited 2023 Feb 15];
3. Baumeister J, Chatain N, Sofias AM, Lammers T, Koschmieder S. Progression of myeloproliferative neoplasms (MPN): diagnostic and therapeutic perspectives. Cells [Internet]. 202110(12). https://pubmed.ncbi.nlm.nih.gov/34944059/ [cited 2023 Feb 15]
4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJP, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell [Internet]. 2005 7(4):387–397. https://pubmed.ncbi.nlm.nih.gov/15837627/ [cited 2023 Feb 15];
5. Harrison DA. The JAK/STAT pathway. Cold Spring Harb Perspect Biol [Internet]. 2012;4(3). /pmc/articles/PMC3282412/ [cited 2023 Feb 15]
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献